openPR Logo
Press release

Biomarkers Market: Huge Growth Opportunities | Industry Trends | Market Analysis & Global Forecast to 2027

01-24-2020 06:50 PM CET | Health & Medicine

Press release from: Allied Market Research

/ PR Agency: Allied Market Research
Biomarkers Market

Biomarkers Market

Global Industry Analysis, Emerging Technologies, Competitive Intelligence, Growth Trends, Size, Share, Opportunities and Forecast, 2013 - 2020" published by Allied Market Research, the global biomarkers market for diagnostic applications such as risk assessment, molecular diagnostic, disease diagnosis, drug discovery & development, drug formulation, forensic and other such applications is set to reach about $30.6 billion in 2020 growing at CAGR of 16% from 2013 to 2020. Disease diagnostic remains the key application segment that is expected to reach $6.1 billion in 2020. However application of diagnostic biomarkers in forensics and molecular diagnostics is catching up quite significantly with latter expected to experience a growth rate of 17.6% during 2013 and 2020.

The complete report is available at http://www.alliedmarketresearch.com/biomarkers-market=87

"Diagnostic biomarkers continue to address challenges such as early and accurate diagnosis of most of the fatal diseases. Increasing advancements with extended applications of diagnostic biomarkers are only going to increase its significance in the field of diagnostics" according to AMR analysts Debbie Shields and Roshan Deshmukh. "Diagnostic biomarker technology is expected to change the scenario of drug development and medical practice, as technologies are metamorphosing from traditional pathophysiology/epidemiology approach to biomarker studies such as genomics and proteomic" add the analysts.

Diagnostic biomarkers though are a great tool in molecular diagnostics, is facing challenges with respect to ethical and regulatory issues as these are related to genomic pattern of an individual which needs to be extremely confidential.

This report segments the global diagnostic biomarker on the basis of diagnostic biomarker types, applications and service. Applications market further segments as risk assessment, molecular diagnostics, disease diagnosis, drug discovery and development, drug formulation, forensic applications and others. The report particularly focuses on biomarkers for diagnostic applications and excludes clinical trials and research.

Download the Sample Report @ https://www.alliedmarketresearch.com/request-sample/87

With respect to geography, Asia Pacific is expected to have the highest CAGR at 20.3% from 2013 to 2020. Companies profiled in this report include Roche Diagnostic Limited (Switzerland), Siemens Healthcare (Germany), Abbott Laboratories Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Agilent Technologies Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), Aushon BioSystem Inc. (U.S.), Epistem Ltd. (U.K.), G.E. Healthcare Inc. (U.K)

Related Report:

COPD and Asthma Devices Market
https://www.medgadget.com/2019/01/asthma-and-copd-drugs-market-size-is-anticipated-to-reach-a-valuation-50359-million-by-2022.html

New Zealand Medical Imaging Services Market
https://www.medgadget.com/2019/05/new-zealand-medical-imaging-services-market-has-taken-a-rapid-growth-in-upcoming-years-2025.html

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Life Science Market: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biomarkers Market: Huge Growth Opportunities | Industry Trends | Market Analysis & Global Forecast to 2027 here

News-ID: 1908225 • Views: 178

More Releases from Allied Market Research

Pathological Examination Market to Reach $438.16 Bn, Globally, by 2025 at 12.3% …
Pathological Examination Market by Type (Traditional Pathology and Digital Pathology) and Application (Digestive Organs and Other Applications): Global Opportunity Analysis and Industry Forecast, 2017 - 2025. The research offers a detailed analysis on changing market dynamics, key investment pockets, major segments, and market competition. According to the report, the global pathological examination market generated $171.08 billion in 2017, and is expected to reach $438.16 billion by 2025, growing at a
Biochip Market Growth by $21.42 Bn, Globally at Expected CAGR In Upcoming Year R …
"Biochip Market by Product (DNA Chips, Protein Chips, Lab-On-A-Chip, and Others), Application (Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture, and Other), and End User (Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostics Centers, Academic & Research Institutes, and Other): Global Opportunity Analysis and Industry Forecast, 2019-2027". The report presents a detailed analysis of the driving factors & opportunities, top-winning strategies, business performance of key players, top investment pockets, and
Abdominal Aortic Aneurysm Repair Devices Market is Expected to Touch a Value of …
UPDATE AVAILABLE ON-DEMAND Global abdominal aortic aneurysm repair devices market was valued at $1,844 million in 2015, and is estimated to reach $2,614 million by 2022, registering a CAGR of 5.1% from 2016 to 2022. The endovascular stent graft system segment is expected to generate the highest revenue, and is projected to dominate the market during the study period. Abdominal aortic aneurysm (AAA) is a condition that affects majorly the geriatric population
Laparoscopy Device Market in Indian is Estimated to Grasp $811 Million by 2023 w …
UPDATE AVAILABLE ON-DEMAND The Indian Laparoscopy Devices Market was valued at $490 million in 2016, and is projected to reach $811 million by 2023, growing at a CAGR of 7.3% from 2017 to 2023. The energy devices segment accounted for one fourth share of the total market in 2016. Laparoscopy is a minimally invasive surgical procedure that assists in the diagnosis of various abdominal and pelvic disorders, such as cysts, adhesions, fibroids,

All 5 Releases


More Releases for Biomarkers

Biomarkers Market Fragmented by 2025
Global Biomarkers Market: Snapshot The global biomarkers market is witnessing a tremendous rise in its valuation, thanks to the increase in diagnostic applications of biomarkers. The augmenting investments for research and development activities in the pharma and biotech companies, rising number of CROs, and the low cost associated with the clinical trials in emerging economies are also boosting this market. Going forward, the high prevalence rate of cancer and novel initiatives for
Cancer Biomarkers Market: Regional Overview
Cancer is the second-leading cause of death worldwide (World Health Organization). There were around 14 million new cases of cancer reported across the globe in 2012 and the incidence rate is expected to increase by around 70% by 2030 (WHO). The most common cancer types are lung cancer, liver cancer, colorectal cancer, stomach cancer, and breast cancer. Cancer therapies are expensive and the cost rises with increase in complexity or stage
Cancer Molecular Biomarkers Market
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body. A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments. On the basis of diagnostics, the cancer molecular
Biomarkers Market : Analysis & Trends 2023
Global Biomarkers Market A biomarker refers to a biological molecule or gene that is used to effectively and accurately evaluate pharmacologic responses, pathogenic procedures, and biological procedures. Also known as a molecular marker or signature molecule, biomarkers are found in blood, other body fluids, and tissue. Extensively used to see the body’s response to a particular treatment for a disease or condition, biomarkers assist medical professionals to take effective clinical decisions
Global Vocal Biomarkers Market
The Global Vocal Biomarkers Market is estimated to be valued at US$ 6.4 million by 2017 and is projected to expand at an astounding CAGR of 65.7% from 2017 to 2028, as analyzed by Coherent Market Insights. Vocal biomarkers enabling early diagnosis and being a non-invasive procedure are analyzed to be major factor fueling uptake of this disruptive technology over the forecast period (2017–2028). Mental and physical conditions such as anxiety
Biomarkers Summit
SMi present their 4th annual conference on Biomarkers Summit Monday 31st January & Tuesday 1st February 2011 Crowne Plaza The-City, London, UK Don’t Miss Out - Visit to register your place today http://www.smi-online.co.uk/preclinical-biomarkers.asp Sponsored by Caprotec Cell Signalling Technology GVK Bio Selventa Millipore Quest Diagnostics RBM SMi’s highly anticipated 4th annual Biomarkers Summit is fast approaching, and time is running out